by CharTeam1 | Apr 23, 2021 | Clinical Trials
Disease registry encompassing the care of patients with multiple myeloma on panobinostat. Participants will describe current treatment patterns and characterize adverse events in the first or later lines of therapy. Outcomes reported in RECOMM Registry
by CharTeam1 | Apr 23, 2021 | Clinical Trials
Phase 3 study comparing niraparib plus pembrolizumab versus placebo plus pembrolizumab as maintenance therapy for patients that have remained stable or responded to first line platinum based chemo plus pembrolizumab for stage IIIB or IV non-small cell lung cancer...
by CharTeam1 | Apr 23, 2021 | Clinical Trials
A survivorship edpidemiology study describing the long-term real-world use and effectiveness of cemiplimab for cutaneous squamous cell carcinoma (CSCC).
by CharTeam1 | Apr 23, 2021 | Clinical Trials
Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard-of-care therapies for the treatment of stage 4 non-small cell lung cancer (NSCLC) following platinum failure.
by CharTeam1 | Apr 7, 2021 | Front Page News, Uncategorized
What is your role at OSC? Certified Nurse Practitioner What is your Educational Background? I went to the University of South Carolina for my nursing degree and then the Medical University of SC (MUSC) for my NP degree. I am originally from Columbia, SC Why did you...
